Category Regulatory

Genetix Biotherapeutics to Share U.S. Gene Therapy Patient Experience Data at ASH 2025

Genetix Biotherapeutics to Highlight U.S. Gene Therapy Implementation and Patient Experience Data at ASH 2025 Genetix Biotherapeutics Inc. announced that an analysis of recent patient experience data from the U.S. commercial implementation of its landmark gene therapies LYFGENIA™ and ZYNTEGLO™…

Read MoreGenetix Biotherapeutics to Share U.S. Gene Therapy Patient Experience Data at ASH 2025

Taiho Pharma Licenses PI3Kα Inhibitor Risovalisib to Haihe Biopharma

Taiho Pharma and Haihe Biopharma Form Exclusive Japanese Partnership for PI3Kα Inhibitor Risovalisib Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an exclusive license agreement for the development, manufacturing, and commercialization of…

Read MoreTaiho Pharma Licenses PI3Kα Inhibitor Risovalisib to Haihe Biopharma